Siemens Healthcare Diagnostics – PFA-100 Platelet Function Analyzer
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The National Institutes of Health (NIH), Clinical Center, intends to award a sole-source firm-fixed-price purchase order to Siemens Healthcare Diagnostics for one PFA-100 Platelet Function Analyzer and a barcode scanner. This acquisition is crucial for ensuring uninterrupted platelet function testing for patient care and clinical research. While this is not a request for quotations, interested parties may submit capability statements.
Scope of Requirement
The Department of Laboratory Medicine requires a replacement PFA-100 Platelet Function Analyzer (Part #10459298) and a Barcode Scanner/Cable (Part #11539138). The existing instrument has exceeded its service life and is no longer reliable, necessitating this replacement to support critical clinical patient testing and NIH clinical research activities.
Sole Source Rationale
This acquisition is being conducted as a sole-source under FAR 13.106-1(b)(1) because the PFA-100 utilizes proprietary manufacturer-specific cartridges, reagents, and validated methodologies. Siemens Healthcare Diagnostics is identified as the only source capable of providing a new instrument that maintains compatibility with existing validated testing methods, laboratory workflows, and clinical result interpretation standards. Substituting another platform would require extensive validation and could adversely impact patient care.
Contract & Timeline
- Type: Intended Sole-Source Firm-Fixed-Price Purchase Order
- Authority: FAR 13.106-1(b)(1) – Soliciting from a Single Source
- Place of Performance: NIH Clinical Center, Bethesda, MD 20892
- Response Due (Capability Statements): June 24, 2026, at 11:30 AM EST
- Published: June 15, 2026
Submission Requirements for Capability Statements
Interested parties demonstrating an ability to provide an equivalent solution must include:
- Company name and address
- Technical capability
- Documentation proving compatibility with existing validated testing methods
- Proof of manufacturer authorization (if applicable)
- Relevant past performance
Additional Notes
This notice is for informational purposes only and does not constitute a request for quotations. The determination not to compete this requirement is solely at the Government's discretion.